Tentative Biochemical Approach to Fenofibrate Efficacy in Tinnitus Aurium

  • M. Strolin-Benedetti
  • E. Chesne
  • P. Dostert
  • H. Cao Danh
Conference paper
Part of the Proceedings in Life Sciences book series (LIFE SCIENCES)

Abstract

Reduced blood flow in the inner ear may be one cause of tinnitus and similar disorders of hearing. In this case, inner ear tissue could be in a chronic hypoxic state, that is the oxygen supply to the tissue is insufficient, as postulated by Frèche and Tronche (1983).

Keywords

Propionate Adenosine Beach Fibrinogen Triphosphate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benesch R, Benesch RE (1967) The effect of organic phosphates from the human erythrocyte on the allosteric properties of hemoglobin. Biochim Biophys Res Commun 26:162–167CrossRefGoogle Scholar
  2. Drabkin DL (1948) The standardization of hemoglobin measurement. Am J Med Sci 215:110–111PubMedCrossRefGoogle Scholar
  3. Faed EM, McQueen EG (1974) Serum Clofibrate concentrations in patients on continuous medication. Pharmacology 12:144–151PubMedCrossRefGoogle Scholar
  4. Frèche H, Tronche R (1983) Les pièges de la pathologie ischémique en ORL. In: Le malade isché-mique. Gaz Med, Fr 90(30):22–24Google Scholar
  5. Gurrieri J, Le Lous M, Renson FJ, Tourne C, Voegelin H, Majoie B, Wulfert E (1976) Antilipidemic drugs, Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl — [4′(p chloro-benzoyl) 2 phenoxy-2-methyl] propionate (LF 178). Arzneimitt Forsch 28:3–20Google Scholar
  6. Jaworek O, Grüber W, Bergmeyer HU (1974) Adenosine -5′-triphosphate. Determination with 3-phosphoglycerate kinase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Chemie International, Deerfield Beach, pp 2097–2101Google Scholar
  7. Ledermann H, Kaufmann B (1981) Comparative pharmacokinetics of 400 mg bezafibrate after a single oral administration of a new slow-release preparation and the currently available commercial form. J Int Med Res 9:516–520PubMedGoogle Scholar
  8. Le Devehat C, Lemoine A, Cirette B, Ramet M (1981) Pharmacological influences of pentoxifylline on red cell filterability and 2,3-diphosphoglycerate. Scand J Clin Lab Invest 41(156):301–303CrossRefGoogle Scholar
  9. Lowe GDO, Stromberg P, Forbes CD, McArdle BM, Lorimer AR, Prentice CRM (1982) Increased blood viscosity and fibrinolytic inhibitor in type II hyper-lipoproteinaemia. Lancet 1:472–475PubMedCrossRefGoogle Scholar
  10. Maeda N, Imaizumi K, Sekiya M, Shiga T (1984) Rheological characteristics of desialylated erythrocytes in relation to fibrinogen-induced aggregation. Biochim Biophys Acta 776:151–158PubMedCrossRefGoogle Scholar
  11. Michal G (1974) 2,3-diphosphoglycerate. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Chemie International, Deerfield Beach, pp 1433–1438Google Scholar
  12. Müller R (1981) Hemorheology and peripheral vascular diseases: a new therapeutic approach. J Med 12(4):209–235PubMedGoogle Scholar
  13. Perutz MF (1970) Stereochemistry of cooperative effects in hemoglobin Bohr effect and combination with organic phosphates. Nature (London) 228(5273):734–739CrossRefGoogle Scholar
  14. Perutz MF, Poyart C (1983) Bezafibrate lowers oxygen affinity of haemoglobin. Lancet 2:881–882PubMedCrossRefGoogle Scholar
  15. Vigneron C, Stoltz JF (1977) Modifications physico-chimique et rhéologique de l’hématie sous l’influence de la pentoxifylline. Med Acta 4:200–204Google Scholar
  16. Weed RI, La Celle PL, Merrill W (1969) Metabolic dependence of red cell deformability. J Clin Invest 48:795–809PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • M. Strolin-Benedetti
  • E. Chesne
  • P. Dostert
  • H. Cao Danh
    • 1
  1. 1.Laboratoires FournierCentre de Recherches de DaixFontaine les DijonFrance

Personalised recommendations